What is NDC 59651-825?

59651-825 is the product NDC for Cimetidine, Cimetidine 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cimetidine?

21 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cimetidine NDC 59651-825 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-825Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0825Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-825-01	5965108250159651082501	100 TABLET, FILM COATED in 1 BOTTLE (59651-825-01)Marketed from Nov 12, 2024
59651-825-05	5965108250559651082505	500 TABLET, FILM COATED in 1 BOTTLE (59651-825-05)Marketed from Nov 12, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cimetidine
Generic name (nonproprietary): cimetidine
Active ingredients: Cimetidine — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218997
Marketing start: Nov 12, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 59651-825_ebd53065-c080-4045-a398-64d3f3b1460fSPL ID ebd53065-c080-4045-a398-64d3f3b1460fSPL set ID ebd53065-c080-4045-a398-64d3f3b1460fRxCUI 197505, 197506, 197507, 197508UNII 80061L1WGD
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651082501 followed by a unit qualifier and the quantity

Package 59651-0825-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 14, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cimetidine tablets are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks and there is rarely reason to use cimetidine tablets at full dosage for longer than 6 to 8 weeks (see DOSAGE AND ADMINISTRATION: Duodenal Ulcer ). Concomitant antacids should be given as needed for relief of pain. However, simultaneous administration of cimetidine tablets and antacids is not recommended, since antacids have been reported to interfere with the absorption of cimetidine. 2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. Patients have been maintained on continued treatment with cimetidine …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-825

What is NDC 59651-825?: 59651-825 is the product NDC for Cimetidine, Cimetidine 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cimetidine.
What is the active ingredient?: Cimetidine.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cimetidine?: 21 other product NDCs are listed under this name. See all Cimetidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cimetidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cimetidine	Cimetidine 200 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-323	69452-0323-2069452-0323-30
Cimetidine	Cimetidine 300 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-324	69452-0324-2069452-0324-30
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-325	69452-0325-2069452-0325-30
Cimetidine	Cimetidine 800 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-326	69452-0326-2069452-0326-30
Cimetidine	Cimetidine 800 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-826	59651-0826-01
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	Northwind Health Company, LLC	51655-697	51655-0697-51
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-0500	50090-0500-0050090-0500-01
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-333	63187-0333-30
Cimetidine	Cimetidine 800 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-8305	00093-8305-01
Cimetidine	Cimetidine 300 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-8192	00093-8192-0100093-8192-05

All 22 Cimetidine NDCs

Other NDCs under ANDA 218997

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218997
Product	Strength	Form · route	Labeler	Product NDC
Cimetidine	Cimetidine 800 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-826